SCHEMBL18017971

SCHEMBL18017971

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc(-c6cccc(-c7nc(-c8ccc(-c9ccccc9)cc8)c8c(n7)sc7ccccc78)c6)c5)c4)nc4oc5ccccc5c34)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ ELANE P08246 1/20 0.33
▸ PLA2G10 O15496 1/20 0.32
▸ ADORA2A P29274 6/20 0.32
▸ ADORA1 P30542 5/20 0.32
▸ WHR1 P49842 1/20 0.31
▸ HPGD P15428 3/20 0.31
▸ MEN1 O00255 3/20 0.30
▸ KMT2A Q03164 3/20 0.30
▸ ATM Q13315 1/20 0.30
▸ MAPT P10636 2/20 0.30
▸ TBK1 Q9UHD2 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18017973 1.00 PLA2G2A (0.34) PLA2G2APLA2G4AELANEPLA2G10ADORA2A
SCHEMBL18017968 1.00 PLA2G2A (0.34) PLA2G2APLA2G4AELANEPLA2G10ADORA2A
SCHEMBL18018008 0.99 PLA2G2A (0.33) PLA2G2APLA2G4AELANEPLA2G10ADORA2A
SCHEMBL18017986 0.99 ELANE (0.33) PLA2G2APLA2G4AELANEPLA2G10ADORA2A
SCHEMBL18017949 0.98 ADORA2A (0.33) PLA2G2APLA2G4AELANEPLA2G10ADORA2A
SCHEMBL18017946 0.98 ADORA2A (0.33) PLA2G2APLA2G4AELANEPLA2G10ADORA2A
SCHEMBL18017970 0.98 ADORA2A (0.33) PLA2G2APLA2G4AELANEPLA2G10ADORA2A
SCHEMBL18017829 0.98 ELANE (0.33) PLA2G2APLA2G4AELANEPLA2G10ADORA2A
SCHEMBL18017694 0.98 ELANE (0.34) PLA2G2APLA2G4AELANEPLA2G10ADORA2A
SCHEMBL18017686 0.98 ELANE (0.34) PLA2G2APLA2G4AELANEPLA2G10ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OCIAD1 PLA2G2A 3717/4885PLA2G4A 3856/4885ELANE 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback